Controversial Covid Vaccine Study Published After CDC Delay
WHO:
NBC News - The acting director of the CDC is involved in the blocking of the Covid vaccine study.
Drudge Report - The CDC is the organization that the acting director represents.
WHAT:
AP - The study found that the COVID-19 vaccine was about 55% effective against COVID-19-associated hospitalizations and reduced COVID-19-related trips to emergency departments and urgent care clinics by 50%.
AP - The study was published in JAMA Network Open after being blocked from the CDC's Morbidity and Mortality Weekly Report.
ABC News - The study on COVID-19 vaccine effectiveness was published in a top medical journal after being blocked from a government health journal.
NBC News - A study on the effectiveness of Covid vaccines was previously blocked from publication by the CDC’s acting director.
NBC News - The blocked study has now been published in a different medical journal.
WHERE:
NBC News - The study was published in an outside medical journal, though the specific journal name is not mentioned.
WHEN:
NBC News - The study was published on a Tuesday, though the specific date is not provided.
WHY:
AP - Acting CDC Director Jay Bhattacharya flagged the study, arguing that its design was too vulnerable to false assumptions that could produce flawed results.
Drudge Report - The CDC chief blocked the Covid vaccine study, though the reasons for this action are not specified in the articles.
HOW:
AP - The study used a "test-negative design," which compares vaccinated patients with unvaccinated patients who were admitted to hospitals or visited emergency rooms with respiratory illnesses.
NBC News - The study was published in a different journal after being blocked by the CDC.
(UPDATED June 24, 2026 06:23 UTC)
A recent study published in JAMA Network Open found that the COVID-19 vaccine was approximately 55% effective in preventing hospitalizations related to COVID-19 and reduced visits to emergency departments and urgent care clinics by 50%. The study, which was initially blocked from the CDC's Morbidity and Mortality Weekly Report, utilized a "test-negative design" that compared vaccinated patients with unvaccinated patients who were admitted to hospitals or visited emergency rooms for respiratory illnesses. Acting CDC Director Jay Bhattacharya raised concerns about the study's design, suggesting it was too susceptible to false assumptions that could lead to flawed results.
--
(UPDATED June 24, 2026 01:37 UTC)
A significant study on the effectiveness of COVID-19 vaccines has finally been published in a leading medical journal after facing obstacles that prevented its release in a government health journal. This development highlights ongoing discussions about vaccine research and transparency. The findings are expected to contribute valuable insights to the ongoing conversation about public health and vaccination strategies.
--
(UPDATED June 23, 2026 23:28 UTC)
The acting director of the CDC has been involved in blocking a study on the effectiveness of Covid vaccines, but that study has now been published in a different medical journal. While the specific journal name has not been disclosed, it was released on a Tuesday after previously being blocked by the CDC’s acting director. The reasons behind the decision to block the study remain unspecified.